Organon & Co has a total of 2674 patents globally, out of which 1303 have been granted. Of these 2674 patents, more than 24% patents are active. Europe is where Organon & Co has filed the maximum number of patents, followed by USA and Mexico. Parallelly, Europe seems to be the main focused R&D center and USA is the origin country of Organon & Co.
Organon & Co was founded in 2020 and its predecessor is Organon International founded in 1923. Organon & Co operates as a pharmaceutical company. The Company develops and produces medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies, and asthma. Organon & Co serves customers worldwide. As of March 2022, Organon & Co has a market cap of $8.20 Billion.
Do read about some of the most popular patents of Organon & Co which have been covered by us in this article and also you can find Organon & Co patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Organon & Co patent portfolio.
How many patents does the CEO of Organon & Co have?
The CEO, Kevin Ali have 0 patents.
How many patents does Organon & Co have?
Organon & Co has a total of 2674 patents globally. These patents belong to 577 unique patent families. Out of 2674 patents, 656 patents are active.
How many Organon & Co patents are Alive/Dead?
Worldwide Patents
Patent Families
How Many Patents did Organon & Co File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Organon & Co Applications Filed | Organon & Co Patents Granted |
| 2011 | 30 | 100 |
| 2012 | 6 | 31 |
| 2013 | 3 | 24 |
| 2014 | 1 | 23 |
| 2015 | – | 7 |
| 2016 | – | 4 |
| 2017 | 1 | 1 |
| 2018 | 1 | 2 |
| 2019 | 12 | 1 |
| 2020 | 3 | – |
| 2021 | 2 | 2 |
| 2022 | – | 1 |
Which Organon & Co Drug Patents are Expiring in the Next 10 Years?
The patent no. US7612058B2 which is expiring in Oct, 2025, describing the formulas for treating vascular conditions, diabetes, and obesity, while reducing sterol levels. They contain a peroxisome proliferator-activated receptor activator and a sterol absorption inhibitor like substituted azetidinone or substituted -lactam.
Given below is the list of few drugs patented by Organon & Co accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Zetia | US7612058B2 | Methods For Inhibiting Sterol Absorption | Oct, 2025 |
| Implanon | US8722037B2 | X-Ray Visible Drug Delivery Device | Sep, 2027 |
Interested in knowing about Organon & Co Drug Patents Expiring in the next 10 years?
How Many Patents did Organon & Co File in Different Countries?
Countries in which Organon & Co Filed Patents
| Country | Patents |
| Europe | 186 |
| United States Of America | 154 |
| Mexico | 98 |
| Austria | 96 |
| Korea (South) | 92 |
| Brazil | 91 |
| Argentina | 82 |
| Australia | 81 |
| Spain | 80 |
| Chile | 79 |
| Hong Kong (S.A.R.) | 79 |
| Denmark | 77 |
| India | 76 |
| Taiwan | 72 |
| Singapore | 72 |
| Japan | 72 |
| New Zealand | 66 |
| Russian Federation | 66 |
| Norway | 64 |
| Poland | 63 |
| China | 62 |
| Germany | 60 |
| Peru | 58 |
| South Africa | 57 |
| Canada | 57 |
| Indonesia | 41 |
| Portugal | 41 |
| Viet Nam | 36 |
| Croatia | 35 |
| Philippines | 35 |
| Cyprus | 32 |
| Ukraine | 31 |
| Ecuador | 30 |
| Malaysia | 26 |
| Slovenia | 24 |
| Colombia | 19 |
| Serbia | 18 |
| Czech Republic | 18 |
| Hungary | 13 |
| Slovakia | 13 |
| United Kingdom | 11 |
| Turkey | 8 |
| Finland | 8 |
| Israel | 6 |
| Iceland | 6 |
| Latvia | 4 |
| Uruguay | 3 |
| United Arab Emirates | 2 |
| Luxembourg | 2 |
| Saudi Arabia | 1 |
| Egypt | 1 |
| Netherlands | 1 |
| Honduras | 1 |
| Lithuania | 1 |
| Macao | 1 |
| Montenegro | 1 |
| Tunisia | 1 |
| Costa Rica | 1 |
| El Salvador | 1 |
| Romania | 1 |
| Dominican Republic | 1 |
Where are Research Centers of Organon & Co Patents Located?
10 Best Organon & Co Patents
WO2008156712A1 is the most popular patent in the Organon & Co portfolio. It has received 964 citations so far from companies like Merck Sharp & Dohme Corp, Millennium Pharmaceuticals and GlaxoSmithKline.
Below is the list of 10 most cited patents of Organon & Co:
| Publication Number | Citation Count |
| WO2008156712A1 | 964 |
| WO2011014438A1 | 109 |
| WO2006095014A1 | 99 |
| WO2007065916A1 | 95 |
| WO2010136438A1 | 79 |
| WO2008020081A1 | 67 |
| WO2008033764A2 | 66 |
| WO2006027347A1 | 66 |
| US20050287203A1 | 59 |
| WO2007039563A1 | 55 |
Patents acquired by Organon & Co
Organon & Co has acquired 30 patents from other companies which is not associated with Organon & Co.
Below the table shows the patent acquisition of Organon & Co –
| Company | Patents Families |
| AkzoNobel | 24 |
| Avecia Limited | 1 |
| Diosynth Rtp Inc | 1 |
| Forbes Medi-Tech Inc | 1 |
| Kanebo Ltd | 1 |
| Merck Sharp & Dohme | 1 |
| Zeneca Limited | 1 |
EXCLUSIVE INSIGHTS COMING SOON!
What are Organon & Co‘s key innovation segments?
What Technologies are Covered by Organon & Co?
The chart below distributes patents filed by Organon & Co in different countries on the basis of the technology protected in patents. It also represents the markets where Organon & Co thinks it’s important to protect particular technology inventions.
R&D Focus: How Organon & Co search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Organon & Co?